Universal-Beteiligungs- und Servicegesellschaft’s Krystal Biotech KRYS Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Sell	3,822 -2,407	-39%	-$719K	﹤0.01%	1424
2026 Q1	$1.61M	Buy	6,229 +1,143	+22%	+$304K	﹤0.01%	1330
2025 Q4	$1.25M	Buy	5,086 +61	+1%	+$12.8K	﹤0.01%	1417
2025 Q3	$887K	Buy	5,025 +891	+22%	+$133K	﹤0.01%	1587
2025 Q2	$568K	Sell	4,134 -8,619	-68%	-$1.27M	﹤0.01%	1650
2025 Q1	$2.3M	Sell	12,753 -10,444	-45%	-$1.76M	﹤0.01%	1123
2024 Q4	$3.63M	Buy	+23,197	New	+$4.12M	0.01%	788

Other funds holding KRYS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's KRYS Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Krystal Biotech (KRYS) stake by 39% in Q2 2026, selling an estimated $719K and leaving 3,822 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1424.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in KRYS in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.63M in Q4 2024. 272 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 3,822 shares of Krystal Biotech worth $1.42M as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft sold 2,407 Krystal Biotech shares in Q2 2026, an estimated $719K.
Krystal Biotech made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1424 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Krystal Biotech in Q4 2024 and has held it in 7 quarters since.
Universal-Beteiligungs- und Servicegesellschaft's Krystal Biotech position peaked at $3.63M in Q4 2024.
272 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.